Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.

Catalá-López F, Tobías A, Cameron C, Moher D, Hutton B.

Rheumatol Int. 2014 Nov;34(11):1489-96. doi: 10.1007/s00296-014-2994-2. Epub 2014 Apr 2. Review.

PMID:
24691560
2.

Indirect and mixed treatment comparisons in arthritis research.

Ades AE, Madan J, Welton NJ.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv5-9. doi: 10.1093/rheumatology/ker241. Review.

PMID:
21859707
3.

Graphical tools for network meta-analysis in STATA.

Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G.

PLoS One. 2013 Oct 3;8(10):e76654. doi: 10.1371/journal.pone.0076654. eCollection 2013.

4.

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2017 May 8;5:CD012657. doi: 10.1002/14651858.CD012657. Review.

PMID:
28481462
6.

Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons.

Jansen JP, Crawford B, Bergman G, Stam W.

Value Health. 2008 Sep-Oct;11(5):956-64. doi: 10.1111/j.1524-4733.2008.00347.x. Epub 2008 May 16. Review.

7.

The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.

Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L.

J Evid Based Med. 2015 Feb;8(1):2-10. doi: 10.1111/jebm.12141. Review.

8.

Additional considerations are required when preparing a protocol for a systematic review with multiple interventions.

Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G.

J Clin Epidemiol. 2017 Mar;83:65-74. doi: 10.1016/j.jclinepi.2016.11.015. Epub 2017 Jan 11.

PMID:
28088593
9.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
10.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934
12.

Indirect comparisons of competing interventions.

Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ; International Stroke Trial Collaborative Group.

Health Technol Assess. 2005 Jul;9(26):1-134, iii-iv.

13.

Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, Jürgens G.

PLoS One. 2014 Sep 22;9(9):e106408. doi: 10.1371/journal.pone.0106408. eCollection 2014. Review.

14.

Comparative effectiveness of biologics for the management of rheumatoid arthritis: systematic review and network meta-analysis.

Alfonso-Cristancho R, Armstrong N, Arjunji R, Riemsma R, Worthy G, Ganguly R, Kleijnen J.

Clin Rheumatol. 2017 Jan;36(1):25-34. doi: 10.1007/s10067-016-3435-2. Epub 2016 Oct 10. Review.

PMID:
27726046
15.

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.

Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe DJ, Bombardier C.

Cochrane Database Syst Rev. 2016 Aug 29;(8):CD010227. doi: 10.1002/14651858.CD010227.pub2. Review.

PMID:
27571502
16.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

17.

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials.

Strand V, Ahadieh S, French J, Geier J, Krishnaswami S, Menon S, Checchio T, Tensfeldt TG, Hoffman E, Riese R, Boy M, Gómez-Reino JJ.

Arthritis Res Ther. 2015 Dec 15;17:362. doi: 10.1186/s13075-015-0880-2. Review.

18.

Reporting of results from network meta-analyses: methodological systematic review.

Bafeta A, Trinquart L, Seror R, Ravaud P.

BMJ. 2014 Mar 11;348:g1741. doi: 10.1136/bmj.g1741. Review.

19.

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 Nov 17;11:CD012437. Review.

PMID:
27855242
20.

[Is it possible to compare different studies on efficacy of biologicals in patients with rheumatoid arthritis? : mixed treatment comparison as a new tool for indirect comparison of clinical studies].

Krüger K, Hellmich B, Rubbert-Roth A, Müller-Ladner U, Kielhorn A.

Z Rheumatol. 2011 Aug;70(6):517-24. doi: 10.1007/s00393-011-0827-1. Review. German.

PMID:
21698473

Supplemental Content

Support Center